1. Home
  2. AIZ vs ABVX Comparison

AIZ vs ABVX Comparison

Compare AIZ & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assurant Inc.

AIZ

Assurant Inc.

HOLD

Current Price

$232.62

Market Cap

11.4B

Sector

Finance

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$119.34

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIZ
ABVX
Founded
1892
2013
Country
United States
France
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
9.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIZ
ABVX
Price
$232.62
$119.34
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$249.17
$112.83
AVG Volume (30 Days)
284.0K
1.7M
Earning Date
11-04-2025
08-11-2025
Dividend Yield
1.54%
N/A
EPS Growth
17.21
N/A
EPS
16.41
N/A
Revenue
$12,568,700,000.00
$7,073,400.00
Revenue This Year
$8.50
$6.80
Revenue Next Year
$5.73
N/A
P/E Ratio
$13.97
N/A
Revenue Growth
6.92
N/A
52 Week Low
$174.97
$4.77
52 Week High
$232.02
$138.49

Technical Indicators

Market Signals
Indicator
AIZ
ABVX
Relative Strength Index (RSI) 67.05 53.15
Support Level $219.63 $107.06
Resistance Level $226.59 $138.49
Average True Range (ATR) 3.72 7.25
MACD 0.28 -0.35
Stochastic Oscillator 95.02 37.95

Price Performance

Historical Comparison
AIZ
ABVX

About AIZ Assurant Inc.

Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: